Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Common Stock | Options Exercise | +1.03K | +1.53% | 68.1K | Sep 10, 2022 | Direct | F1 | ||
transaction | GILD | Common Stock | Tax liability | -$31.1K | -476 | -0.7% | $65.28 | 67.6K | Sep 10, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Restricted Stock Unit | Options Exercise | -1.03K | -2.12% | 47.4K | Sep 10, 2022 | Common Stock | 1.03K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
F2 | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |